Safety and Efficacy Trial of AAV Gene Therapy in Patients With CNGA3 Achromatopsia (A Clarity Clinical Trial)
Clinical trial NCT02935517 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02935517
- Sponsor
- Beacon Therapeutics
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-03
- Primary completion
- 2022-08-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.